CELC
Price
$55.69
Change
+$1.22 (+2.24%)
Updated
Sep 5 closing price
Capitalization
2.36B
72 days until earnings call
DOSEF
Price
$1.00
Change
-$0.02 (-1.96%)
Updated
Aug 14 closing price
Capitalization
1.63M
Interact to see
Advertisement

CELC vs DOSEF

Header iconCELC vs DOSEF Comparison
Open Charts CELC vs DOSEFBanner chart's image
Celcuity
Price$55.69
Change+$1.22 (+2.24%)
Volume$831.71K
Capitalization2.36B
Doseology Sciences
Price$1.00
Change-$0.02 (-1.96%)
Volume$1.86K
Capitalization1.63M
CELC vs DOSEF Comparison Chart in %
Loading...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DOSEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CELC vs. DOSEF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a StrongBuy and DOSEF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CELC: $55.69 vs. DOSEF: $1.00)
Brand notoriety: CELC and DOSEF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELC: 53% vs. DOSEF: 99%
Market capitalization -- CELC: $2.36B vs. DOSEF: $1.63M
CELC [@Biotechnology] is valued at $2.36B. DOSEF’s [@Biotechnology] market capitalization is $1.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELC’s FA Score shows that 1 FA rating(s) are green whileDOSEF’s FA Score has 0 green FA rating(s).

  • CELC’s FA Score: 1 green, 4 red.
  • DOSEF’s FA Score: 0 green, 5 red.
According to our system of comparison, CELC is a better buy in the long-term than DOSEF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELC’s TA Score shows that 3 TA indicator(s) are bullish while DOSEF’s TA Score has 3 bullish TA indicator(s).

  • CELC’s TA Score: 3 bullish, 5 bearish.
  • DOSEF’s TA Score: 3 bullish, 1 bearish.
According to our system of comparison, DOSEF is a better buy in the short-term than CELC.

Price Growth

CELC (@Biotechnology) experienced а +8.70% price change this week, while DOSEF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

CELC is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CELC($2.36B) has a higher market cap than DOSEF($1.63M). DOSEF YTD gains are higher at: 611.744 vs. CELC (325.401). DOSEF has higher annual earnings (EBITDA): -296.52K vs. CELC (-135.56M). CELC has more cash in the bank: 168M vs. DOSEF (820K). DOSEF has less debt than CELC: DOSEF (0) vs CELC (99.4M). DOSEF has higher revenues than CELC: DOSEF (46.7K) vs CELC (0).
CELCDOSEFCELC / DOSEF
Capitalization2.36B1.63M144,880%
EBITDA-135.56M-296.52K45,717%
Gain YTD325.401611.74453%
P/E RatioN/AN/A-
Revenue046.7K-
Total Cash168M820K20,488%
Total Debt99.4M0-
FUNDAMENTALS RATINGS
CELC: Fundamental Ratings
CELC
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
22
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CELCDOSEF
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
58%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 4 days ago
55%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
56%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
54%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
44%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 18 days ago
86%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
78%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DOSEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WCMRX25.91N/A
N/A
WCM Focused International Growth Inv
FNRCX42.67N/A
N/A
Fidelity Advisor Energy C
HSUAX41.70N/A
N/A
Rational Dynamic Brands A
FTWRX19.03N/A
N/A
Templeton World R6
VSGEX7.46N/A
N/A
Virtus SGA International Growth C

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been closely correlated with IMA. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if CELC jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
+2.23%
IMA - CELC
84%
Closely correlated
-5.80%
NEVPF - CELC
61%
Loosely correlated
N/A
BEAM - CELC
45%
Loosely correlated
+12.62%
CLDX - CELC
44%
Loosely correlated
+0.40%
ABOS - CELC
43%
Loosely correlated
+4.35%
More

DOSEF and

Correlation & Price change

A.I.dvisor tells us that DOSEF and PHGE have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DOSEF and PHGE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DOSEF
1D Price
Change %
DOSEF100%
N/A
PHGE - DOSEF
31%
Poorly correlated
-0.04%
BYSI - DOSEF
27%
Poorly correlated
+1.09%
ALDX - DOSEF
27%
Poorly correlated
+0.54%
NKTX - DOSEF
25%
Poorly correlated
+6.10%
CELC - DOSEF
22%
Poorly correlated
+2.23%
More